This company is included in Intelligence Lab

Verve Therapeutics

Verve Therapeutics logo

Website
https://www.vervetx.com/about-us/
Founded
2019

Verve is focused on discovering and developing therapies that safely edit the genomes of adults to confer protection against coronary artery disease, the most common type of heart disease and the leading cause of death worldwide.

Articles Mentioning This Company

11 Biopharma Trends to Watch in 2024

     Business Intelligence
2023 has marked a remarkable year of technological advancements in drug discovery and biotechnology. Ironically, the elation from a kaleidoscope of technological and scientific advances is in stark contrast with the overall industry’s economic performance—it was also a rough year for biopharma overall. There are signs that 2024 might be better …